Abstract
Transient Receptor Potential Vanilloid Type 1 is a prominent “pain” receptor expressed in sensory afferent neurons. TRPV1 on peripheral nerve terminals detects a variety of noxious stimuli generated at sites of injury and inflammation, and in turn, drives the excitation and sensitization of C-fiber neurons. Significantly, TRPV1 is also located on the central terminals of sensory neurons projecting to the spinal cord and brainstem. These TRPV1 channels appear to stimulate the secretion of glutamate. Further, TRPV1 is expressed diffusely in the brain and there is emerging evidence for TRPV1 modulating transmission at various brain synapses. Here we discuss our current understanding of the potential roles for TRPV1 in synaptic transmission.
Keywords: Brain, CNS, pain, presynaptic, spinal cord, TRPV1, Synaptic Transmission, sensory afferent neurons, capsaicin, synaptophysin, noxious stimuli, amygdala, periaqueductal gray, TRPV1 mRNA, tetrodotoxin, vanilloids, eicosanoids, (PKC) activation, PIP2, mEPSCs, TRPV1 channels, PKC stimulation, hippocampal neurons, presynaptic dopamine receptors, EPSC amplitude, endovanilloids, dopaminergic neurons, GABAergic transmission, nociceptive responses, neurohypophysis, capsazepine, PLC signaling
Current Pharmaceutical Biotechnology
Title: TRPV1 and Synaptic Transmission
Volume: 12 Issue: 1
Author(s): Jose A. Matta and Gerard P. Ahern
Affiliation:
Keywords: Brain, CNS, pain, presynaptic, spinal cord, TRPV1, Synaptic Transmission, sensory afferent neurons, capsaicin, synaptophysin, noxious stimuli, amygdala, periaqueductal gray, TRPV1 mRNA, tetrodotoxin, vanilloids, eicosanoids, (PKC) activation, PIP2, mEPSCs, TRPV1 channels, PKC stimulation, hippocampal neurons, presynaptic dopamine receptors, EPSC amplitude, endovanilloids, dopaminergic neurons, GABAergic transmission, nociceptive responses, neurohypophysis, capsazepine, PLC signaling
Abstract: Transient Receptor Potential Vanilloid Type 1 is a prominent “pain” receptor expressed in sensory afferent neurons. TRPV1 on peripheral nerve terminals detects a variety of noxious stimuli generated at sites of injury and inflammation, and in turn, drives the excitation and sensitization of C-fiber neurons. Significantly, TRPV1 is also located on the central terminals of sensory neurons projecting to the spinal cord and brainstem. These TRPV1 channels appear to stimulate the secretion of glutamate. Further, TRPV1 is expressed diffusely in the brain and there is emerging evidence for TRPV1 modulating transmission at various brain synapses. Here we discuss our current understanding of the potential roles for TRPV1 in synaptic transmission.
Export Options
About this article
Cite this article as:
A. Matta Jose and P. Ahern Gerard, TRPV1 and Synaptic Transmission, Current Pharmaceutical Biotechnology 2011; 12 (1) . https://dx.doi.org/10.2174/138920111793937925
DOI https://dx.doi.org/10.2174/138920111793937925 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial (Hot Topic: Epidemiology & Risk Factors for Alzheimer’s Disease)
Current Alzheimer Research Heat Shock Proteins And Neuroprotection
Recent Patents on DNA & Gene Sequences Alpha-7 Nicotinic Receptors in Nervous System Disorders: From Function to Therapeutic Perspectives
Central Nervous System Agents in Medicinal Chemistry Increasing Neurogenesis with Fluoxetine, Simvastatin and Ascorbic Acid Leads to Functional Recovery in Ischemic Stroke
Recent Patents on Drug Delivery & Formulation Lipids in the Diet and the Fatty Acid Profile in Beef: A Review and Recent Patents on the Topic
Recent Patents on Food, Nutrition & Agriculture Soluble Neuregulin-1 from Microglia Enhances Amyloid Beta-induced Neuronal Death
CNS & Neurological Disorders - Drug Targets Gut Emotions - Mechanisms of Action of Probiotics as Novel Therapeutic Targets for Depression and Anxiety Disorders
CNS & Neurological Disorders - Drug Targets A Case of Topiramate-Induced Epistaxis
Current Drug Safety Currently Used Antimycotics: Spectrum, Mode of Action and Resistance Occurrence
Current Drug Targets Synthesis and Some Reactions of 1-aryl-4-acetyl-5-methyl-1,2,3-triazole Derivatives with Anticonvulsant Activity
Mini-Reviews in Medicinal Chemistry Soothing the Inflamed Brain: Effect of Non-Steroidal Anti-Inflammatory Drugs on Alzheimers Disease Pathology
CNS & Neurological Disorders - Drug Targets Origins, Controversies and Recent Developments of the MCI Construct
Current Alzheimer Research Neurorestorative Role of Stem Cells in Alzheimer’s Disease: Astrocyte Involvement
Current Alzheimer Research Editorial [Is Drug Safety Dangerous?]
Current Drug Safety Copper (II) Complexes of [1,2,4]Triazolo [1,5-a]Pyrimidine Derivatives as Potential Anti-Parasitic Agents
Drug Metabolism Letters Inflammasome in Dendritic Cells Immunobiology: Implications to Diseases and Therapeutic Strategies
Current Drug Targets Structural Variation of Chondroitin Sulfate and Its Roles in the Central Nervous System
Central Nervous System Agents in Medicinal Chemistry Poor Safety and Tolerability Hamper Reaching a Potentially Therapeutic Dose in the Use of Thalidomide for Alzheimer’s Disease: Results from a Double-Blind, Placebo-Controlled Trial
Current Alzheimer Research Intervertebral Disc Engineering through Exploiting Mesenchymal Stem Cells: Progress and Perspective
Current Stem Cell Research & Therapy Cross Talk Among Leukocytes, Platelets, and Endothelial Cells and its Relevance to Atherosclerosis and Coronary Heart Disease
Current Nutrition & Food Science